Following the pledge by the Food and Drug Administration to step up efforts regarding its programme for ensuring the validity of the scientific data used to support product approval applications, Mark Elengold describes the ins and outs of the system.
The US Food and Drug Administration has currently listed on its website the names of 145 clinical investigators who have been disqualified or are pending disqualification from participating in the development of new medical devices or drugs...
Please login to read the full article.
